Cell-Membrane-Coated Lipid Nanoparticles for Ultrasound Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene carriers, such as cationic liposomes and microbubbles, face challenges in achieving precise transfection due to lack of specific targeting, stability, and efficient intracellular delivery, with cationic nanoparticles adsorbing proteins and being cleared by the immune system, and biomimetic nanoparticles failing to incorporate nucleic acids due to charge interactions.
Innovation Solution
A biomimetic ultrasound responsive lipid nanoparticle is developed, using a cationic core with charge reversal and encapsulated PFP, integrating a cell membrane to form a stable core-shell structure, enabling efficient gene delivery through acoustic pores under ultrasound.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cationic liposomes are used as gene carriers, then transfection efficiency is improved, but blood compatibility deteriorates and immune clearance increases
Solution Approach 1:
The patent changes the surface charge parameter of the nanoparticle from positive to negative by coating with cell membrane, which fundamentally alters the interaction with blood components and immune cells, thereby improving blood compatibility while maintaining transfection efficiency through the underlying cationic core
Solution Approach 2:
The patent creates a composite structure with a cationic lipid nanoparticle core for gene delivery and a cell membrane outer layer for biological compatibility. This composite design combines the transfection advantage of cationic materials with the blood compatibility advantage of biomimetic membranes
2Object-affected harmful factors
If biomimetic nanoparticles with negative surface potential are used, then blood compatibility is improved, but nucleic acid loading capability deteriorates
Solution Approach 1:
The patent divides the nanoparticle into two functional segments: a cationic core that provides nucleic acid loading capability through charge adsorption, and a cell membrane coating that provides blood compatibility. This segmentation allows each part to independently perform its specialized function without interfering with the other
Solution Approach 2:
The patent implements a nested structure where the cell membrane coating envelops the cationic nanoparticle core. The inner core maintains its positive charge for nucleic acid binding, while the outer membrane provides the negative surface potential for improved blood compatibility, creating a hierarchical functional architecture
3Object-affected harmful factors
If cationic nanoparticles are coated with cell membrane, then blood compatibility is improved, but charge adsorption capability deteriorates
Solution Approach 1:
The patent applies local quality by creating different charge characteristics at different locations of the nanoparticle: the inner core maintains cationic charge for reliable nucleic acid adsorption, while the outer surface exhibits anionic charge from the cell membrane for improved blood compatibility. Each region performs its specialized function locally
4Ease of manufacture
If conventional nano carriers are used, then ease of manufacture is improved, but targeting capability deteriorates
Solution Approach 1:
The patent uses copying by obtaining cell membranes from specific cell types and coating them onto the nanoparticle core. This copying of the cell membrane's surface characteristics provides inherent targeting capability that directs the carrier to specific tissues or cells, while the basic nanoparticle preparation process remains relatively simple
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticle achieves targeted and efficient intracellular gene delivery, enhancing stability and circulation time, and improving transfection efficiency while avoiding immune clearance.
Implementation Method 1
adding a cell membrane component to the lipid shell component of the nanoparticle by an acoustic vibration method
Implementation Method 2
liquid gas phase transition occurs under ultrasonic irradiation
Implementation Method 3
blasting occurs under continuous ultrasonic irradiation, the blasting energy generated forms reversible acoustic holes on the surface of the cell membrane
Implementation Method 4
Its surface is connected with small molecule nucleic acids based on the principle of charge adsorption
Data Source
AI summary
An ultrasound responsive lipid nanoparticle carrying genes and a cell membrane is provided, which can simultaneously carry small molecule nucleic acids and a cell membrane, and can be used as a gene transfection carrier in vivo. Its surface is connected with small molecule nucleic acids based on the principle of charge adsorption, a component of a cell membrane is mixed in a surface lipid layer, PFP is encapsulated inside the nanoparticle, liquid gas phase transition occurs under ultrasonic irradiation, and blasting occurs under continuous ultrasonic irradiation, the blasting energy generated forms reversible acoustic holes on the surface of the cell membrane, and a drug released after blasting is driven by a blasting driving force to directly enter an interior of the cell through the acoustic holes, realizing an efficient release and transfection of nucleic acids in the cell.